Circulating Osteopontin: A Dual Marker of Bone Destruction and Angiogenesis in Patients With Multiple Myeloma
Journal of Hematology and Oncology - United Kingdom
doi 10.1186/1756-8722-4-22
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2011
Authors
Publisher
Springer Science and Business Media LLC